| Schedule of restatement of previously issued balance sheet |
| |
|
July 19, 2021 |
|
| |
|
As Previously
Reported |
|
|
Adjustments |
|
|
As Revised |
|
| Balance Sheet (unaudited) |
|
|
|
|
|
|
|
|
|
| Common stock subject to possible redemption |
|
$ |
154,073,040 |
|
|
$ |
7,818,210 |
|
|
$ |
161,891,250 |
|
| Allocation of underwriter’s discounts, offering costs and deferred fees to shares |
|
|
— |
|
|
|
(3,657,956 |
) |
|
|
(3,657,956 |
) |
| Immediate accretion to redemption value |
|
|
— |
|
|
|
15,991,706 |
|
|
|
15,991,706 |
|
| Total common stock subject to possible redemption |
|
|
154,073,040 |
|
|
|
20,151,960 |
|
|
|
174,225,000 |
|
| Common stock |
|
|
631 |
|
|
|
(200 |
) |
|
|
431 |
|
| Additional paid-in capital |
|
|
5,258,926 |
|
|
|
(5,258,926 |
) |
|
|
— |
|
| Accumulated deficit |
|
|
(259,547 |
) |
|
|
(14,892,834 |
) |
|
|
(15,152,381 |
) |
| Total stockholders’ equity (deficit) |
|
$ |
5,000,010 |
|
|
$ |
(20,151,960 |
) |
|
$ |
(15,151,950 |
) |
|
| Schedule of condensed balance sheet are reconciled |
| Gross proceeds |
|
$ |
172,500,000 |
|
| Less: |
|
|
|
|
| Proceeds allocated to Public Warrants |
|
|
(10,608,750 |
) |
| Issuance costs allocated to common stock |
|
|
(3,657,956 |
) |
| Plus: |
|
|
|
|
| Accretion of carrying value to redemption value |
|
|
15,991,706 |
|
| Common stock subject to possible redemption |
|
$ |
174,225,000 |
|
|
| Schedule of basic and diluted net income (loss) per common share |
| |
|
Three Months
Ended
September 30,
2021 |
|
|
Nine Months
Ended
September 30,
2021 |
|
|
Three Months
Ended
September 30,
2020 |
|
|
For the period
from June 18,
2020
(inception)
through
September 30,
2020 |
|
| Basic and diluted net income (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
| Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) |
|
$ |
3,341,073 |
|
|
$ |
3,341,073 |
|
|
$ |
— |
|
|
$ |
(1,000 |
) |
| Denominator |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic and diluted weighted average shares outstanding (1) |
|
|
17,760,989 |
|
|
|
9,904,182 |
|
|
|
3,750,000 |
|
|
|
3,750,000 |
|
| Basic and diluted net income (loss) per share of common stock |
|
$ |
0.19 |
|
|
$ |
0.34 |
|
|
$ |
0.00 |
|
|
$ |
(0.00 |
) |
|